ArticlePloS one2014

Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner.

Roberta M Moretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.